EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA : results of a round robin trial

The European Commision (EC) recently approved osimertinib for the treatment of adult patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) harboring EGFR T790M mutations. Besides tissue-based testing, blood samples containing cell-free circulating tumor DNA (ctDNA) can be u...

Full description

Bibliographic Details
Published in:Virchows Archiv, 471(2017), 4, Seite 509-520
Main Author: Fassunke, Jana (Author)
Other Involved Persons: Penzel, Roland ; Volckmar, Anna-Lena ; Stenzinger, Albrecht ; Endris, Volker ; Schirmacher, Peter
Format: Article
Language:English
Published: 8 September 2017
ISSN:1432-2307
Item Description:Gesehen am 08.10.2018
Im Titel ist "EGFR" kursiv geschrieben
Physical Description:12
DOI:10.1007/s00428-017-2226-8
Subjects:
QR Code: Show QR Code